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Abstract
Background and aims: This study was carried out to investigate the incidence, annual time trend
and some epidemiological and clinical features of Guillain-Barre syndrome in children in the north
west of Iran.
Materials and methods: In this population-based cross sectional research, epidemiological and
clinical features of 143 cases with Guillain-Barre syndrome between 2001 and 2006 were studied.
The setting of the study was Tabriz Children Medical Centre, the major University-Hospital located
in Tabriz city of the East Azarbaijan province covering whole region. Data collected included age,
gender, chronological information, preceding events, functional grade of motor deficit.
Results: The mean age (standard deviation) of subjects was 5.4 (3.6) years. The male/female ratio
was 1.3. The average annual incidence rate was 2.27 per 100 000 population of 15 years children
(CI95%: 1.9–2.6). The majority of cases occurred in March, July and November and the highest
proportion of the syndrome was observed in winter (29 percent, P > 0.10).
Conclusion: The results indicated that an unexpected high incidence of Guillain-Barre syndrome
has occurred in 2003 in the region. We concluded that a monitoring and surveillance system for
Guillain-Barre syndrome is essential to set up in this region.
Background
Guillain-Barre syndrome is an autoimmune disorder of
peripheral nervous system causing progressive weakness
and areflexia. Since the marked decline in poliomyelitis
incidence, the syndrome is now the most common cause
of acute flaccid paralysis in many countries [1]. Epidemi-
ologic studies have reported an annual incidence of 0.16–
4 (mostly between 1–2) cases per 100 000 population
from different countries [2-10]. Although the disease is
considered to be sporadic without significant variation
over time, some studies have shown annual and seasonal
trends [5-8,11-13].
The aim of this study was to investigate the incidence,
annual time trend and some epidemiological and clinical
features of Guillain-Barre syndrome in children in the
north west of Iran.
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Methods
East Azerbaijan is located in the northwest of Iran, a cold
climate zone. It has a total area of 47 821 km2. According
to the official census data, the total population of children
0–15 years was estimated 6465267 over the study period.
In this population-based cross sectional research, medical
history and clinical features of 143 cases with Guillain-
Barre syndrome between 2001 and 2006 were studied.
The setting of the study was Tabriz Children Medical Cen-
tre, is the largest children medical center in the north-west
area of Iran. This medical centre is a 200-bed acute care
university hospital providing tertiary referral care for criti-
cally ill patients.
As part of World Health Organization's (WHO) certifica-
tion process for polio eradication, Iran has been systemat-
ically registering children under 15 years old with acute
flaccid paralysis since 1995. However, the local policy for
acute flaccid paralysis (AFP) surveillance program is that
all cases of AFP should be referred to Tabriz Children
Medical Centre. All subjects are routinely examined by
expert child neurologist (Mohammad Barzegar, the prin-
cipal investigator of this project) within 7 days of notifica-
tion. The GBS cases (under 16 years) were then diagnosed
and aascertained based on the criteria defined and intro-
duced by Asbury and Cornblath [1].
Data collected included age, gender, chronological infor-
mation, preceding events, neurological features func-
tional grade of motor deficit and laboratory findings. The
functional status at the time of maximum deficit was
graded according to Hughes scale of disability as follows:
0: healthy, 1: minor signs and symptoms and is capable of
running; 2: able to walk 5 meters without assistance, but
is unable to run. 3: able to walk with assistance, 4: con-
fined to bed or chair bound, 5: requires assisted ventila-
tion, and 6: died [14].
Poliovirus infection was excluded by cultures that are rou-
tinely performed for patients with acute flaccid paralysis
as a requirement of the national program of poliomyelitis
eradication.
All children underwent at least one electro diagnostic
evaluation at the acute phase of disease (from day 1 to 27,
average 6.5 days). A Medelec Synergy electromyography
machine was used for this assessment. Nerve conduction
studies included motor nerve conduction (MNC), sensory
nerve conduction (SNC), and F-wave response studies
were performed using the standard techniques of
supramaximal percutaneous nerve stimulation and sur-
face electrode recording. MNC studies were done on the
ulnar, tibial and deep peroneal nerves and SNC on
median and sural nerves. Each value of nerve conduction
was compared with age matched normal data reported by
Parano and colleagues [15]. Needle EMG was done for
any denervation and motor unit action potential changes
in all patients in at least two proximal and two distal limb
muscles. Patients were classified as having axonal or
demyelinating type based on the electrodiagnostic criteria
reported by Cornblath and colleagues [16]. For each
patient, the first neurophysiologic study was reviewed.
Approval for this study was obtained from National Pub-
lic Health Management Centre of Tabriz University of
Medical Sciences where a funded project is routinely
assessed/approved in terms of methodology, ethical and
financial issues.
Incidence rates and descriptive statistics were calculated to
document the epidemiological features of the Guillain-
Barre syndrome in the area. Data from the Ministry of
Health, Statistics Office, were used to estimate the
expected frequencies of the syndrome in the East Azarbai-
jan province to assess the time trend.
Results
Between 2001 and 2006, one hundred forty three cases of
Guillain-Barre syndrome were diagnosed and ascertained
in Tabriz Children university-hospital of Tabriz University
of Medical Sciences, East Azarbaijan province, Iran.
Table-1 shows the basic characteristics of the study sub-
jects. The mean age (standard deviation) of cases was 5.4
(3.6) years (range: 1–15 years). The male/female ratio was
1.3. The functional grade of motor deficit was scored 4 in
the majority of the cases (67.1%). Fifteen patients
(10.5%) received assisted ventilation, and two (1.4%)
died. In electrodiagnostic study, three patterns emerged:
demyelinating type (53.8%), axonal type (35%), and
11.2% as normal.
Upper respiratory tract infections were most common pre-
ceding infection in winter (72.5%). Sensory symptoms,
mostly as limbs pain were observed in 43 patients
(30.1%). Cranial nerve involvement was also observed in
about 40% of patients. Bulbar weakness (22%) was the
most common type of cranial nerve involvement followed
by facial palsy (17%).
The average annual incidence rate was 2.27 per 100 000
population of 15 years children (CI95%: 1.9–2.6) in the
area ranging from 1.5 to 3.4 in different years.
There was a marginal significant variation in the trend in
incidence rates (per 100 000 population of 15 years chil-
dren) of Guillain-Barre syndrome between 2001 and
2006 indicating that an unexpected high incidence of syn-
drome has occurred in 2003 in the region (Table 2). TheBMC Neurology 2007, 7:22 http://www.biomedcentral.com/1471-2377/7/22
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same trend was again observed for the year 2003 when the
observed frequencies of the syndrome at the same region
were compared to the expected values (Figure 1).
Figure 2 shows the occurrence of the Guillain-Barre syn-
drome in the north west of Iran by calendar months. The
majority of cases occurred in March, July and November
in the whole study period. The lowest and highest propor-
tion of the syndrome occurred in spring (19.6 percent)
and winter (28.7 percent), respectively (P > 0.10).
Dsicussion
We investigated the incidence, annual time trend and
occurrence of Guillain-Barre syndrome in children in the
north west of Iran.
Tabriz Children Hospital is the reference inpatient center
for child neurology in the north-west of Iran. Therefore it
is unlikely that patients with suspected Guillain-Barre syn-
drome were not visited/diagnosed/ascertained at this
medical centre. However it is possible that some cases
may have been missed, especially those with minor clini-
cal signs and symptoms (grade 1) not requiring hospitali-
zation. In our research, clinical features and incidence rate
were similar to those reported from other studies [2-
6,8,10-13].
In our study, the average incidence rate was slightly higher
than those reported from most areas in the world (within
the range between 0.16 to 4 cases per 100 000). However
if we exclude the cases from year 2003, our incidence rate
decrease to 2 cases per 100 000 population which is con-
sistent with other reports [5-8,11,12].
The highest incidence in the year 2003 could not be
related to any pathogen agent as campylobacter jejuni is
not routinely detected in our medical centre. However in
an investigation carried out by authors from January 2003
to march 2005 in the same region, serological evidence of
recent campylobacter jejuni infection was found in about
half of children with Guillain-Barre syndrome [17].
Outbreaks of the disease have been reported from differ-
ent areas in the last few decades. Investigators from Greece
have reported an outbreak in year 2002 [5]. A similar fea-
ture was studied/reported in Sweden in 1985 and 1992
[18]. An increased incidence of Guillain-Barre syndrome
in the USA for 1976 was attributed to 'swine flu" vaccines
Table 1: Basic and clinical characteristics of the study subjects with Guillain-Barre syndrome
Mean Standard Deviation
Age (years) 5.4 3.6
Median time to peak 
disability(days)
4.7 3.7
Number Percent
Sex Male 81 56.5
Female 62 43.5
Preceding events 
Upper Respiratory infection 75 52.4
Gastroenteritis 20 14
other  42 . 8
None  44 30.8
Seasonal incidence 
winter  41 28.7
spring 28 19.6
summer  38 26.6
autumn 36 25.2
Functional Grading 2 85 . 6
of disease 3 24 16.8
4 96 67.1
5 13 9.1
6 21 . 4
Cranial nerve Involvement 57 39.9
Autonomic dysfunction  21 14.7
Sensory symptoms (limbs pain) 43 30.1BMC Neurology 2007, 7:22 http://www.biomedcentral.com/1471-2377/7/22
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[19]. Another study from Caribbean island of Curacao
showed that incidence rose sharply from 1.62 (per 100
000) between 1987 and 1991 to 3.10 (per 100 000)
between 1992 and 1999 [20].
Although the disease is considered to be sporadic without
significant variation between seasons and months, small
clusters occurred in March, July and November and the
highest proportion of the syndrome was observed in the
winter. Small clusters have been associated with outbreaks
of bacterial enteritis caused by contaminated water. A
research report from China indicated that summer epi-
demics of the syndrome might be caused by campylo-
bacter jejuni infection [21]. In a study from Saudi Arabia,
analysis of seasonal incidence has also shown that 40% of
the cases occurred in the cold seasons with the highest
peak in February [12]. In our study, clustering of patients
in winter could be related to the high frequency of upper
respiratory infection during cold season.
The percentage of antecedent infectious disease in the sub-
jects in our investigation was almost similar to the average
proportions reported from previous studies [2-8,10-13].
In the time period of 2002–3, a similar high frequency of
Guillain-Barre syndrome was reported from the whole
country (including neighboring provinces of study area).
In seeking to explain this pattern, possible impact of some
environmental causal or influencing factors can not be
ruled out. More studies are needed to investigate the etiol-
ogy of this time pattern.
The epidemiology of GBS is not easy to investigate
because of the difficulties in case definition and the
absence of a reference standard diagnostic test. Further-
more, objective physiologic abnormalities of nerve dys-
function may be difficult to detect at early stages. The
difference in the incidence rates reported from different
regions might then be partly explained by case definition,
the design and methodology of the investigations (i.e.
study design, population based vs hospital based settings,
case ascertainment, etc).
Conclusion
In conclusion, this study showed an unexpected occur-
rence of Guillain-Barre syndrome in the area and the
whole country for 2003 indicating the necessity of an epi-
demiological surveillance system in the region for proper
intervention in possible outbreaks in the future.
Occurrence of the Guillain-Barre syndrome in the north  west of Iran by calendar months Figure 2
Occurrence of the Guillain-Barre syndrome in the north 
west of Iran by calendar months.
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Table 2: Incidence of the Guillain-Barre syndrome in the north west of Iran
Diagnosis year Incidence (per 100 000) 95% Confidence Intervals
2001 1.49 (0.8,2.4)
2002 1.95 (1.2,2.9)
2003 3.44 (2.4,4.7)
2004 2.14 (1.3,3.2)
2005 2.04 (1.2,3.1)
2006 2.57 (1.7,3.7)
Observed and expected frequency of the Guillain-Barre syn- drome in the north west of Iran Figure 1
Observed and expected frequency of the Guillain-Barre syn-
drome in the north west of Iran.
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